Caisse DE Depot ET Placement DU Quebec Sells 64,277 Shares of CME Group Inc. (NASDAQ:CME)

Caisse DE Depot ET Placement DU Quebec lessened its position in CME Group Inc. (NASDAQ:CME - Free Report) by 75.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 21,185 shares of the financial services provider's stock after selling 64,277 shares during the quarter. Caisse DE Depot ET Placement DU Quebec's holdings in CME Group were worth $4,920,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. SJS Investment Consulting Inc. grew its stake in shares of CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock worth $26,000 after buying an additional 97 shares in the last quarter. New Age Alpha Advisors LLC increased its stake in shares of CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after acquiring an additional 43 shares during the period. Financial Life Planners acquired a new position in CME Group in the fourth quarter valued at approximately $32,000. Knuff & Co LLC acquired a new position in CME Group during the fourth quarter worth $33,000. Finally, Fortitude Family Office LLC raised its stake in CME Group by 120.3% in the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider's stock valued at $35,000 after purchasing an additional 83 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

CME Group Stock Performance

Shares of CME stock traded up $2.36 during trading hours on Friday, reaching $284.35. 936,061 shares of the company traded hands, compared to its average volume of 2,153,197. The company has a market cap of $102.47 billion, a P/E ratio of 29.41, a P/E/G ratio of 6.76 and a beta of 0.45. The firm has a 50-day moving average price of $263.82 and a 200 day moving average price of $245.14. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $286.48. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.61 by $0.19. The firm had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. CME Group's revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.50 EPS. As a group, sell-side analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be paid a $1.25 dividend. The ex-dividend date is Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.76%. CME Group's dividend payout ratio (DPR) is 50.30%.

Analyst Ratings Changes

CME has been the subject of several research analyst reports. Bank of America raised their price target on CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research report on Wednesday, April 2nd. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $269.00 price objective on shares of CME Group in a report on Thursday, April 3rd. Keefe, Bruyette & Woods lifted their target price on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a research report on Thursday, April 24th. Erste Group Bank raised shares of CME Group to a "strong-buy" rating in a research note on Monday, March 17th. Finally, Barclays lifted their price objective on shares of CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a research note on Wednesday, April 23rd. Three analysts have rated the stock with a sell rating, seven have issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $256.80.

Insider Transactions at CME Group

In other news, Director Dennis Suskind sold 1,000 shares of the firm's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total transaction of $271,280.00. Following the completion of the transaction, the director now owns 2,915 shares in the company, valued at approximately $790,781.20. This trade represents a 25.54 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Hilda Harris Piell sold 3,984 shares of the firm's stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $250.47, for a total value of $997,872.48. Following the sale, the insider now owns 27,046 shares of the company's stock, valued at $6,774,211.62. The trade was a 12.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 34,726 shares of company stock valued at $8,975,813. 0.30% of the stock is currently owned by corporate insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.